Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 108,220 | 90,059 | 107,680 | 97,862 | 100,806 |
| Gross Profit | 108,220 | 90,059 | 107,680 | 97,862 | 100,806 |
| Operating Expenses | 25,666 | 12,330 | 3,153 | 3,309 | 4,266 |
| Operating Income | 82,554 | 77,729 | 104,527 | 94,553 | 96,540 |
| Interest Expense | 3,655 | 3,010 | 4,841 | 4,790 | 4,745 |
| Other Income | -58,404 | -30,001 | -43,197 | 33,414 | 44,384 |
| Pre-tax Income | 20,495 | 44,718 | 56,489 | 123,177 | 136,179 |
| Income Tax | -876 | 6,860 | 10,839 | 20,531 | 25,333 |
| Net Income Continuous | 21,371 | 37,858 | 45,650 | 102,646 | 110,846 |
| Minority Interests | 20,432 | 22,085 | 35,305 | 30,208 | 21,898 |
| Net Income | $939 | $15,773 | $10,345 | $72,438 | $88,948 |
| EPS Basic Total Ops | 0.01 | 0.23 | 0.26 | 1.04 | 1.01 |
| EPS Basic Continuous Ops | 0.31 | 0.54 | 0.68 | 1.48 | 1.25 |
| EPS Diluted Total Ops | 0.01 | 0.20 | 0.23 | 0.90 | 0.90 |
| EPS Diluted Continuous Ops | 0.22 | 0.40 | 0.59 | 1.26 | 1.10 |
| EBITDA(a) | $86,699 | $81,607 | $110,341 | $100,317 | $102,259 |